Works by Chi, Kim N.

Results: 75

The impact of time to metastasis on overall survival in patients with prostate cancer.

Published in:

World Journal of Urology, 2018, v. 36, n. 7, p. 1039, doi. 10.1007/s00345-018-2236-4

By:

Frees, Sebastian;
Akamatsu, Shusuke;
Bidnur, Samir;
Khalaf, Daniel;
Chavez-Munoz, Claudia;
Struss, Werner;
Eigl, Bernhard J.;
Gleave, Martin;
Chi, Kim N.;
So, Alan

Publication type:

Article

A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.

Published in:

NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00366-z

By:

Ritch, Elie J.;
Herberts, Cameron;
Warner, Evan W.;
Ng, Sarah W. S.;
Kwan, Edmond M.;
Bacon, Jack V. W.;
Bernales, Cecily Q.;
Schönlau, Elena;
Fonseca, Nicolette M.;
Giri, Veda N.;
Maurice-Dror, Corinne;
Vandekerkhove, Gillian;
Jones, Steven J. M.;
Chi, Kim N.;
Wyatt, Alexander W.

Publication type:

Article

Comparative Survival of Asian and White Metastatic Castration-Resistant Prostate Cancer Men Treated With Docetaxel.

Published in:

JNCI Cancer Spectrum, 2020, v. 4, n. 2, p. 1, doi. 10.1093/jncics/pkaa003

By:

Halabi, Susan;
Dutta, Sandipan;
Tangen, Catherine M;
Rosenthal, Mark;
Petrylak, Daniel P;
Thompson, Ian M;
Chi, Kim N;
Bono, Johann S De;
Araujo, John C;
Logothetis, Christopher;
Eisenberger, Mario A;
Quinn, David I;
Fizazi, Karim;
Morris, Michael J;
Higano, Celestia S;
Tannock, Ian F;
Small, Eric J;
Kelly, William Kevin

Publication type:

Article

Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progression.

Published in:

Molecular Oncology, 2016, v. 10, n. 5, p. 693, doi. 10.1016/j.molonc.2015.12.010

By:

Crea, Francesco;
Quagliata, Luca;
Michael, Agnieszka;
Liu, Hui Hsuan;
Frumento, Paolo;
Azad, Arun A.;
Xue, Hui;
Pikor, Larissa;
Watahiki, Akira;
Morant, Rudolf;
Eppenberger-Castori, Serenella;
Wang, Yuwei;
Parolia, Abhijit;
Lennox, Kim A.;
Lam, Wan L.;
Gleave, Martin;
Chi, Kim N.;
Pandha, Hardev;
Wang, Yuzhuo;
Helgason, Cheryl D.

Publication type:

Article

Apalutamide efficacy, safety and wellbeing in older patients with advanced prostate cancer from Phase 3 randomised clinical studies TITAN and SPARTAN.

Published in:

British Journal of Cancer, 2024, v. 130, n. 1, p. 73, doi. 10.1038/s41416-023-02492-8

By:

Shen, John;
Chowdhury, Simon;
Agarwal, Neeraj;
Karsh, Lawrence I.;
Oudard, Stéphane;
Gartrell, Benjamin A.;
Feyerabend, Susan;
Saad, Fred;
Pieczonka, Christopher M.;
Chi, Kim N.;
Brookman-May, Sabine D.;
Rooney, Brendan;
Bhaumik, Amitabha;
McCarthy, Sharon A.;
Bevans, Katherine B.;
Mundle, Suneel D.;
Small, Eric J.;
Smith, Matthew R.;
Graff, Julie N.

Publication type:

Article

A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer.

Published in:

Investigational New Drugs, 2005, v. 23, n. 4, p. 311, doi. 10.1007/s10637-005-1439-x

By:

Kim N. Chi;
Stephen K. Chia;
Ross Dixon;
Michael J. Newman;
Vince J. Wacher;
Branimir Sikic;
Karen A. Gelmon

Publication type:

Article

Frequent mutation of the FOXA1 untranslated region in prostate cancer.

Published in:

Communications Biology, 2018, v. 1, n. 1, p. N.PAG, doi. 10.1038/s42003-018-0128-1

By:

Annala, Matti;
Taavitsainen, Sinja;
Vandekerkhove, Gillian;
Bacon, Jack V. W.;
Beja, Kevin;
Chi, Kim N.;
Nykter, Matti;
Wyatt, Alexander W.

Publication type:

Article

Prostate‐specific antigen kinetics in Asian patients with metastatic castration‐sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysis.

Published in:

International Journal of Urology, 2025, v. 32, n. 2, p. 164, doi. 10.1111/iju.15615

By:

Ye, Ding‐Wei;
Uemura, Hirotsugu;
Chung, Byung Ha;
Suzuki, Hiroyoshi;
Mundle, Suneel;
Bhaumik, Amitabha;
Singh, Anildeep;
Chowdhury, Simon;
Agarwal, Neeraj;
Chi, Kim N.;
Huang, Jian

Publication type:

Article

Safety and efficacy of apalutamide in Japanese patients with metastatic castration‐sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo‐controlled, phase III TITAN study

Published in:

International Journal of Urology, 2022, v. 29, n. 6, p. 533, doi. 10.1111/iju.14843

By:

Uemura, Hirotsugu;
Arai, Gaku;
Uemura, Hiroji;
Suzuki, Hiroyoshi;
Aoyama, Junya;
Hatayama, Tomoyoshi;
Ito, Miku;
Lefresne, Florence;
McCarthy, Sharon;
Mundle, Suneel;
He, Jin;
Chi, Kim N

Publication type:

Article

Apalutamide for metastatic, castration‐sensitive prostate cancer in the Japanese population: A subgroup analysis of the randomized, double‐blind, placebo‐controlled phase 3 TITAN study.

Published in:

International Journal of Urology, 2021, v. 28, n. 3, p. 280, doi. 10.1111/iju.14447

By:

Uemura, Hirotsugu;
Arai, Gaku;
Uemura, Hiroji;
Suzuki, Hiroyoshi;
Iijima, Kazuyoshi;
Nishimura, Kazuo;
Fujii, Koji;
Hatayama, Tomoyoshi;
Aoyama, Junya;
Deprince, Kris;
Lopez‐Gitlitz, Angela;
McCarthy, Sharon;
Larsen, Julie S;
Li, Jinhui;
Chi, Kim N

Publication type:

Article

Chemotherapy for metastatic castration-sensitive prostate cancer.

Published in:

International Journal of Urology, 2016, v. 23, n. 9, p. 726, doi. 10.1111/iju.13148

By:

Parimi, Sunil;
Chi, Kim N

Publication type:

Article

Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054497

By:

Kwan, Edmond M.;
Wyatt, Alexander W.;
Chi, Kim N.

Publication type:

Article

Comprehensive immune profiling of patients with advanced urothelial or renal cell carcinoma receiving immune checkpoint blockade.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.973402

By:

Lavoie, Jean-Michel;
Baichoo, Priya;
Chavez, Elizabeth;
Nappi, Lucia;
Khalaf, Daniel;
Kollmannsberger, Christian K.;
Chi, Kim N.;
Weng, Andrew;
Steidl, Christian;
Eigl, Bernhard J.;
Nissen, Michael

Publication type:

Article

Review: Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions.

Published in:

Therapeutic Advances in Medical Oncology, 2010, v. 2, n. 1, p. 39, doi. 10.1177/1758834009352498

By:

Heng, Daniel Y.C.;
Kollmannsberger, Christian;
Chi, Kim N.

Publication type:

Article

Biallelic tumour suppressor loss and DNA repair defects in de novo small‐cell prostate carcinoma.

Published in:

Journal of Pathology, 2018, v. 246, n. 2, p. 244, doi. 10.1002/path.5137

By:

Chedgy, Edmund C. P.;
Vandekerkhove, Gillian;
Herberts, Cameron;
Annala, Matti;
Donoghue, Adam J.;
Sigouros, Michael;
Ritch, Elie;
Struss, Werner;
Konomura, Saki;
Liew, Janet;
Parimi, Sunil;
Vergidis, Joanna;
Hurtado‐Coll, Antonio;
Sboner, Andrea;
Fazli, Ladan;
Beltran, Himisha;
Chi, Kim N.;
Wyatt, Alexander W.

Publication type:

Article

Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial.

Published in:

2016

By:

Leibowitz-Amit, Raya;
Pintilie, Melania;
Khoja, Leila;
Azad, Arun A.;
Berger, Raanan;
Douglas Laird, A.;
Aftab, Dana T.;
Chi, Kim N.;
Joshua, Anthony M.;
Laird, A Douglas

Publication type:

journal article

Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations.

Published in:

JAMA Network Open, 2020, v. 3, n. 10, p. e2021692, doi. 10.1001/jamanetworkopen.2020.21692

By:

Schmid, Sabine;
Omlin, Aurelius;
Higano, Celestia;
Sweeney, Christopher;
Martinez Chanza, Nieves;
Mehra, Niven;
Kuppen, Malou C. P.;
Beltran, Himisha;
Condeduca, Vincenza;
Vargas Pivato de Almeida, Daniel;
Cotait Maluf, Fernando;
Oh, William K.;
Tsao, Che-Kai;
Sartor, Oliver;
Ledet, Elisa;
Di Lorenzo, Giuseppe;
Yip, Steven M.;
Chi, Kim N.;
Bianchini, Diletta;
De Giorgi, Ugo

Publication type:

Article

Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients.

Published in:

Genome Biology, 2016, v. 17, p. 1, doi. 10.1186/s13059-015-0864-1

By:

Lallous, Nada;
Volik, Stanislav V.;
Awrey, Shannon;
Leblanc, Eric;
Tse, Ronnie;
Murillo, Josef;
Singh, Kriti;
Azad, Arun A.;
Wyatt, Alexander W.;
LeBihan, Stephane;
Chi, Kim N.;
Gleave, Martin E.;
Rennie, Paul S.;
Collins, Colin C.;
Cherkasov, Artem

Publication type:

Article

Disparity in public funding of therapies for metastatic castrate-resistant prostate cancer across Canadian provinces.

Published in:

Canadian Urological Association Journal, 2018, v. 12, n. 10, p. 328, doi. 10.5489/cuaj.5378

By:

Woon, Dixon T. S.;
Chandrasekar, Thenappan;
Aaron, Lorne;
Basappa, Naveen S.;
Chi, Kim N.;
Conter, Henry J.;
Gotto, Geoffrey;
Hotte, Sebastien J.;
Malone, Shawn;
Saad, Fred;
Shayegan, Bobby;
Park-Wyllie, Laura;
Hamilton, Robert J.

Publication type:

Article

A prognostic model for stratifying clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer patients treated with abiraterone acetate.

Published in:

Canadian Urological Association Journal, 2018, v. 12, n. 2, p. E47, doi. 10.5489/cuaj.4600

By:

Khalaf, Daniel Joseph;
Avilés, Claudia M.;
Azad, Arun A.;
Sunderland, Katherine;
Todenhöfer, Tilman;
Eigl, Berhard J.;
Finch, Daygen;
Le, Lyly;
Atwell, Andrew;
Keith, Bruce;
Kollmannsberger, Christian;
Chi, Kim. N.

Publication type:

Article

A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion.

Published in:

Canadian Urological Association Journal, 2017, v. 11, n. 10, p. 350, doi. 10.5489/cuaj.4415

By:

Parimi, Sunil;
Tsang, Erica;
Alexander, Abraham;
McKenzie, Michael;
Bachand, Francois;
Sunderland, Katherine;
Chi, Kim N.;
Aparicio, Maria;
Worsley, Daniel;
Tyldesley, Scott

Publication type:

Article

The 2015 CUA-CUOG Guidelines for the management of castration-resistant prostate cancer (CRPC).

Published in:

Canadian Urological Association Journal, 2015, v. 9, n. 3/4, p. 90, doi. 10.5489/cuaj.2526

By:

Saad, Fred;
Chi, Kim N.;
Finelli, Antonio;
Hotte, Sebastien J.;
Izawa, Jonathan;
Kapoor, Anil;
Kassouf, Wassim;
Loblaw, Andrew;
North, Scott;
Rendon, Ricardo;
So, Alan;
Usmani, Nawaid;
Vigneault, Eric;
Fleshner, Neil E.

Publication type:

Article

Treatment of muscle-invasive bladder cancer in Canada: A survey of genitourinary medical oncologists and urologists.

Published in:

Canadian Urological Association Journal, 2014, v. 8, n. 9/10, p. 309, doi. 10.5489/cuaj.2111

By:

Hsu, Tina;
Black, Peter C.;
Chi, Kim N.;
Canil, Christina M.;
Eigl, Bernhard J.;
Kulkarni, Girish;
North, Scott;
Wood, Lori;
Zlotta, Alexandre R.;
Lau, Anthea;
Panzarella, Tony;
Sridhar, Srikala S.

Publication type:

Article

CUA-CUOG guidelines for the management of castration-resistant prostate cancer (CRPC): 2013 update.

Published in:

Canadian Urological Association Journal, 2013, v. 7, n. 7/8, p. 231, doi. 10.5489/cuaj.1542

By:

Saad, Fred;
Hotte, Sebastien;
Catton, Charles;
Drachenberg, Darrel;
Finelli, Antonio;
Fleshner, Neil;
Gleave, Martin;
Kapoor, Anil;
Kassouf, Wassim;
Loblaw, Andrew;
North, Scott;
Usmani, Nawaid;
Chi, Kim N.

Publication type:

Article

Food Effects on Abiraterone Pharmacokinetics in Healthy Subjects and Patients With Metastatic Castration-Resistant Prostate Cancer.

Published in:

Journal of Clinical Pharmacology, 2015, v. 55, n. 12, p. 1406, doi. 10.1002/jcph.564

By:

Chi, Kim N.;
Spratlin, Jennifer;
Kollmannsberger, Christian;
North, Scott;
Pankras, Catherine;
Gonzalez, Martha;
Bernard, Apexa;
Stieltjes, Hans;
Peng, Lixian;
Jiao, James;
Acharya, Milin;
Kheoh, Thian;
Griffin, Thomas W.;
Yu, Margaret K.;
Chien, Caly;
Tran, Nam Phuong

Publication type:

Article

177 Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: A Review of the Evidence and Implications for Canadian Clinical Practice.

Published in:

Current Oncology, 2024, v. 31, n. 3, p. 1400, doi. 10.3390/curroncol31030106

By:

Chi, Kim N.;
Yip, Steven M.;
Bauman, Glenn;
Probst, Stephan;
Emmenegger, Urban;
Kollmannsberger, Christian K.;
Martineau, Patrick;
Niazi, Tamim;
Pouliot, Frédéric;
Rendon, Ricardo;
Hotte, Sebastien J.;
Laidley, David T.;
Saad, Fred

Publication type:

Article

Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 1, p. 1, doi. 10.1093/jnci/djx118

By:

Wyatt, Alexander W.;
Annala, Matti;
Aggarwal, Rahul;
Beja, Kevin;
Felix Feng;
Youngren, Jack;
Foye, Adam;
Lloyd, Paul;
Nykter, Matti;
Beer, Tomasz M.;
Alumkal, Joshi J.;
Thomas, George V.;
Reiter, Robert E.;
Rettig, Matthew B.;
Evans, Christopher P.;
Gao, Allen C.;
Chi, Kim N.;
Small, Eric J.;
Gleave, Martin E.

Publication type:

Article

Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer.

Published in:

2017

By:

Wyatt, Alexander W;
Annala, Matti;
Aggarwal, Rahul;
Beja, Kevin;
Feng, Felix;
Youngren, Jack;
Foye, Adam;
Lloyd, Paul;
Nykter, Matti;
Beer, Tomasz M;
Alumkal, Joshi J;
Thomas, George V;
Reiter, Robert E;
Rettig, Matthew B;
Evans, Christopher P;
Gao, Allen C;
Chi, Kim N;
Small, Eric J;
Gleave, Martin E

Publication type:

journal article

A Phase I Pharmacokinetic and Pharmacodynamic Study of OGX-O11, a 2′-Methoxyethyl Antisense Oligonucleotide to Clusterin, in Patients With Localized Prostate Cancer.

Published in:

JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 17, p. 1287, doi. 10.1093/jnci/dji252

By:

Chi, Kim N.;
Eisenhauer, Elizabeth;
Fazli, Ladan;
Jones, Edward C.;
Goldenberg, S. Larry;
Powers, Jean;
Dongsheng Tu;
Gleave, Martin E.

Publication type:

Article

Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy.

Published in:

Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00543-0

By:

Harsini, Sara;
Wilson, Don;
Saprunoff, Heather;
Allan, Hayley;
Gleave, Martin;
Goldenberg, Larry;
Chi, Kim N.;
Kim-Sing, Charmaine;
Tyldesley, Scott;
Bénard, François

Publication type:

Article

Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.

Published in:

2021

By:

Kwon, Daniel H.;
Chou, Jonathan;
Yip, Steven M.;
Reimers, Melissa A.;
Zhang, Li;
Wright, Francis;
Dhawan, Mallika S.;
Borno, Hala T.;
Desai, Arpita;
Aggarwal, Rahul R.;
Wyatt, Alexander W.;
Small, Eric J.;
Alva, Ajjai S.;
Chi, Kim N.;
Feng, Felix Y.;
Koshkin, Vadim S.

Publication type:

journal article

Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration-naive prostate cancer: Results from LATITUDE.

Published in:

2019

By:

Li, Tracy;
Franco-Villalobos, Conrado;
Proskorovsky, Irina;
Sorensen, Sonja V.;
Tran, NamPhuong;
Sulur, Giri;
Chi, Kim N.

Publication type:

journal article

Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE).

Published in:

2021

By:

Saad, Fred;
Chi, Kim N.;
Shore, Neal D.;
Graff, Julie N.;
Posadas, Edwin M.;
Lattouf, Jean-Baptiste;
Espina, Byron M.;
Zhu, Eugene;
Yu, Alex;
Hazra, Anasuya;
De Meulder, Marc;
Mamidi, Rao N. V. S.;
Bradic, Branislav;
Francis, Peter;
Hayreh, Vinny;
Rezazadeh Kalebasty, Arash

Publication type:

journal article

Continuous Flow Deformability-Based Separation of Circulating Tumor Cells Using Microfluidic Ratchets.

Published in:

Small, 2016, v. 12, n. 14, p. 1909, doi. 10.1002/smll.201503639

By:

Park, Emily S.;
Jin, Chao;
Guo, Quan;
Ang, Richard R.;
Duffy, Simon P.;
Matthews, Kerryn;
Azad, Arun;
Abdi, Hamidreza;
Todenhöfer, Tilman;
Bazov, Jenny;
Chi, Kim N.;
Black, Peter C.;
Ma, Hongshen

Publication type:

Article

2023 European Society for Medical Oncology (ESMO) Congress Meeting highlights.

Published in:

Canadian Urological Association Journal, 2024, v. 18, n. 1, p. E46, doi. 10.5489/cuaj.8688

By:

Chi, Kim N.;
Canil, Christina;
Alimohamed, Nimira;
Soulières, Denis;
Breau, Rodney H.

Publication type:

Article

2023 Canadian Urological Association guideline: Genetic testing in prostate cancer.

Published in:

Canadian Urological Association Journal, 2023, v. 17, n. 10, p. 314, doi. 10.5489/cuaj.8588

By:

Rendon, Ricardo A.;
Selvarajah, Shamini;
Wyatt, Alexander W.;
Kolinsky, Michael;
Schrader, Kasmintan A.;
Fleshner, Neil E.;
Kinnaird, Adam;
Merrimen, Jennifer;
Niazi, Tamim;
Saad, Fred;
Shayegan, Bobby;
Wood, Lori;
Chi, Kim N.

Publication type:

Article

Genetic testing practices among specialist physicians who treat prostate cancer: A Canadian, cross-sectional survey.

Published in:

Canadian Urological Association Journal, 2023, v. 17, n. 10, p. 326, doi. 10.5489/cuaj.8403

By:

Yip, Steven M.;
Morash, Christopher;
Kolinsky, Michael P.;
Kapoor, Anil;
Ong, Michael;
Selvarajah, Shamini;
Nuk, Jennifer;
Compton, Katie;
Pouliot, Frederic;
Lavallée, Luke T.;
Khalaf, Daniel J.;
Hamilton, Robert J.;
Gotto, Geoffrey T.;
Rendon, Ricardo A.;
Antebi, Elie;
Hotte, Sebastien J.;
Malone, Shawn;
Chi, Kim N.;
Drachenberg, Darrel E.;
Saad, Fred

Publication type:

Article

2022 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

Published in:

Canadian Urological Association Journal, 2022, v. 16, n. 11, p. E506, doi. 10.5489/cuaj.8161

By:

Saad, Fred;
Aprikian, Armen;
Finelli, Antonio;
Fleshner, Neil E.;
Gleave, Martin;
Kapoor, Anil;
Niazi, Tamim;
North, Scott A.;
Pouliot, Fréderic;
Rendon, Ricardo A.;
Shayegan, Bobby;
Sridhar, Srikala S.;
So, Alan I.;
Usmani, Nawaid;
Vigneault, Eric;
Chi, Kim N.

Publication type:

Article

Recommendations for the implementation of genetic testing for metastatic prostate cancer patients in Canada.

Published in:

Canadian Urological Association Journal, 2022, v. 16, n. 10, p. 321, doi. 10.5489/cuaj.7954

By:

Selvarajah, Shamini;
Schrader, Kasmintan A.;
Kolinsky, Michael P.;
Rendon, Ricardo A.;
Hallani, Soufiane El;
Fleshner, Neil E.;
Hotte, Sebastien J.;
Lorentz, Justin;
Panabaker, Karen;
Perrier, Renée;
Pouliot, Frédéric;
Spatz, Alan;
Yip, Stephen;
Chi, Kim N.

Publication type:

Article

Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.

Published in:

Canadian Urological Association Journal, 2022, v. 16, n. 4, p. 132, doi. 10.5489/cuaj.7621

By:

Kolinsky, Michael P.;
Niederhoffer, Karen Y.;
Kwan, Edmond M.;
Hotte, Sebastien J.;
Hamilou, Zineb;
Yip, Steven M.;
Chi, Kim N.;
Wyatt, Alexander W.;
Saad, Fred

Publication type:

Article

Prioritizing systemic therapies for genitourinary malignancies: Canadian recommendations during the COVID-19 pandemic.

Published in:

Canadian Urological Association Journal, 2020, v. 14, n. 5, p. E154, doi. 10.5489/cuaj.6595

By:

Lalani, Aly-Khan A.;
Chi, Kim N.;
Heng, Daniel Y. C.;
Kollmannsberger, Christian K.;
Sridhar, Srikala S.;
Blais, Normand;
Canil, Christina;
Czaykowski, Piotr;
Hotte, Sebastien J.;
Iqbal, Nayyer;
Soulières, Denis;
Bossé, Dominick;
Alimohamed, Nimira S.;
Basappa, Naveen S.;
Mukherjee, Som D.;
Winquist, Eric;
Wood, Lori A.;
North, Scott A.

Publication type:

Article

Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancer.

Published in:

Canadian Urological Association Journal, 2020, v. 14, n. 2, p. 17, doi. 10.5489/cuaj.6384

By:

So, Alan I.;
Chi, Kim N.;
Danielson, Brita;
Fleshner, Neil E.;
Kapoor, Anil;
Niazi, Tamim;
Pouliot, Frederic;
Rendon, Ricardo A.;
Shayegan, Bobby;
Sridhar, Srikala;
Vigneault, Eric;
Saad, Fred

Publication type:

Article

2019 Canadian Urological Association (CUA)-Canadian Uro Oncology Group (CUOG) guideline: Management of castration-resistant prostate cancer (CRPC).

Published in:

Canadian Urological Association Journal, 2019, v. 13, n. 10, p. 307, doi. 10.5489/cuaj.6136

By:

Saad, Fred;
Aprikian, Armen;
Finelli, Antonio;
Fleshner, Neil E.;
Gleave, Martin;
Kapoor, Anil;
Niazi, Tamim;
North, Scott A.;
Pouliot, Frederic;
Rendon, Ricardo A.;
Shayegan, Bobby;
Sridhar, Srikala S.;
So, Alan;
Usmani, Nawaid;
Vigneault, Eric;
Chi, Kim N.

Publication type:

Article

Clinical validation of circulating GDF15/MIC‐1 as a marker of response to docetaxel and survival in men with metastatic castration‐resistant prostate cancer.

Published in:

Prostate, 2024, v. 84, n. 8, p. 747, doi. 10.1002/pros.24691

By:

Mahon, Kate L.;
Sutherland, Sarah IM;
Lin, Hui Ming;
Stockler, Martin R.;
Gurney, Howard;
Mallesara, Girish;
Briscoe, Karen;
Marx, Gavin;
Higano, Celestia S.;
de Bono, Johann S.;
Chi, Kim N.;
Clark, Georgina;
Breit, Samuel N.;
Brown, David A.;
Horvath, Lisa G.

Publication type:

Article

Clinical effectiveness of docetaxel for castration‐sensitive prostate cancer in a real‐world population‐based analysis.

Published in:

Prostate, 2019, v. 79, n. 3, p. 281, doi. 10.1002/pros.23733

By:

Lavoie, Jean‐Michel;
Zou, Kevin;
Khalaf, Daniel;
Eigl, Bernhard J.;
Kollmannsberger, Christian K.;
Vergidis, Joanna;
Noonan, Krista;
Zulfiqar, Muhammad;
Finch, Daygen;
Chi, Kim N.

Publication type:

Article

Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Expanded access in North America.

Published in:

Prostate, 2015, v. 75, n. 8, p. 836, doi. 10.1002/pros.22965

By:

Joshua, Anthony M.;
Shore, Neal D.;
Saad, Fred;
Chi, Kim N.;
Olsson, Carl A.;
Emmenegger, Urban;
Scholz, Mark;
Berry, William;
Mukherjee, Som D.;
Winquist, Eric;
Haas, Naomi B.;
Foley, Margaret A.;
Dmuchowski, Carl;
Perabo, Frank;
Hirmand, Mohammad;
Hasabou, Nahla;
Rathkopf, Dana

Publication type:

Article

A retrospective, Canadian multi-center study examining the impact of prior response to abiraterone acetate on efficacy of docetaxel in metastatic castration-resistant prostate cancer.

Published in:

Prostate, 2014, v. 74, n. 15, p. 1544, doi. 10.1002/pros.22872

By:

Azad, Arun A.;
Leibowitz‐Amit, Raya;
Eigl, Bernhard J.;
Lester, Renee;
Wells, J. Connor;
Murray, R. Nevin;
Kollmannsberger, Christian;
Heng, Daniel Y.C.;
Joshua, Anthony M.;
Chi, Kim N.

Publication type:

Article

SELECTING AND SEQUENCING THERAPIES.

Published in:

Oncology Exchange, 2016, v. 15, n. 1, p. 21

By:

Chi, Kim N.

Publication type:

Article

Progress in the treatment o f mCRPC.

Published in:

Oncology Exchange, 2014, v. 13, n. 3, p. 18

By:

Bernard, Brandon;
Azad, Arun A.;
Chi, Kim N.

Publication type:

Article

Phase 1 Study of Safety and Preliminary Clinical Activity of JNJ-63898081, a PSMA and CD3 Bispecific Antibody, for Metastatic Castration-Resistant Prostate Cancer.

Published in:

Clinical Genitourinary Cancer, 2023, v. 21, n. 3, p. 366, doi. 10.1016/j.clgc.2023.02.010

By:

Lim, Emerson A.;
Schweizer, Michael T.;
Chi, Kim N.;
Aggarwal, Rahul;
Agarwal, Neeraj;
Gulley, James;
Attiyeh, Edward;
Greger, James;
Shujian Wu;
Jaiprasart, Pharavee;
Loffredo, John;
Bandyopadhyay, Nibedita;
Hong Xie;
Hansen, Aaron R.

Publication type:

Article